Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-13-000004
Filing Date
2013-03-20
Accepted
2013-03-19 19:00:17
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K a10k-123112.htm 10-K 1294218
2 SUBSIDIARIES ex_21.htm EX-21 3911
3 AUDITORS CONSENT ex_23-1.htm EX-23.1 4042
4 CEO CERTIFICATION ex_31-1.htm EX-31.1 21164
5 CFO CERTIFICATION ex_31-2.htm EX-31.2 21293
6 CEO - CFO CERTIFICATION ex_32.htm EX-3 7804
  Complete submission text file 0000318306-13-000004.txt   8120187

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENTS accp-20121231.xml EX-101.INS 1238363
8 XBRL TAXONOMY SCHEMA accp-20121231.xsd EX-101.SCH 46660
9 XBRL CALCULAZTION LINKBASE accp-20121231_cal.xml EX-101.CAL 63868
10 XBRL DEFINITIVE LINKBASE accp-20121231_def.xml EX-101.DEF 248466
11 XBRL LABEL LINKBASE accp-20121231_lab.xml EX-101.LAB 697282
12 XBRL PRESENTATION LINKBASE accp-20121231_pre.xml EX-101.PRE 390555
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 13703056
SIC: 2834 Pharmaceutical Preparations